Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment (vol 60, pg 23, 2023)

Basit Öğe Kaydı
dc.authoridTERZİ, Murat/0000-0002-3586-9115
dc.authoridYetkin, Mehmet Fatih/0000-0002-2541-7107
dc.authoridşen, sedat/0000-0001-8048-6845
dc.authoridBunul, Sena/0000-0003-4999-2787;
dc.authorwosidEFENDI, HÜSNÜ/JUU-8107-2023
dc.authorwosidTERZİ, Murat/AAA-1284-2021
dc.authorwosidTurkoglu, Sule/ABC-4645-2022
dc.authorwosidSevim, Serhan/KBA-7417-2024
dc.authorwosidBOZ, Cavit/V-5127-2017
dc.authorwosidYetkin, Mehmet Fatih/A-2173-2016
dc.authorwosidşen, sedat/AAB-5529-2020
dc.contributor.authorTerzi, Murat
dc.contributor.authorHelvaci, Elif Merve
dc.contributor.authorSen, Sedat
dc.contributor.authorBoz, Cavit
dc.contributor.authorCilingir, Vedat
dc.contributor.authorAkcali, Aylin
dc.contributor.authorBeckmann, Yesim
dc.date.accessioned2024-06-12T11:22:32Z
dc.date.available2024-06-12T11:22:32Z
dc.date.issued2023
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.29399/npa.28499
dc.identifier.endpage190en_US
dc.identifier.issn1300-0667
dc.identifier.issn1309-4866
dc.identifier.issue2en_US
dc.identifier.pmid37287556en_US
dc.identifier.scopus2-s2.0-85164255146en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage190en_US
dc.identifier.urihttps://doi.org/10.29399/npa.28499
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25975
dc.identifier.volume60en_US
dc.identifier.wosWOS:001021642100017en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Neuropsychiatry Assoc-Turk Noropsikiyatri Dernegien_US
dc.relation.ispartofNoropsikiyatri Arsivi-Archives Of Neuropsychiatryen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleClinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment (vol 60, pg 23, 2023)en_US
dc.typeCorrectionen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu